Inhibition of glycolysis by ethacrynic acid and furosemide.
D000818:Animals; D002462:Cell Membrane; D002474:Cell-Free System; D004229:Dithiothreitol / Q000494:pharmacology; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D004976:Ethacrynic Acid / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005636:Fructosephosphates / Q000378:metabolism; D005665:Furosemide / Q000008:administration & dosage / Q000494:pharmacology*; D005958:Glucosephosphates / Q000378:metabolism; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D006019:Glycolysis / Q000187:drug effects*; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014426:Turtles; D001743:Urinary Bladder / Q000187:drug effects / Q000378:metabolism
D005636:Fructosephosphates; D005958:Glucosephosphates; D007773:Lactates; D005665:Furosemide; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D004976:Ethacrynic Acid; D004229:Dithiothreitol